October 2017

Datum
30/10/2017 IPO Theranexus expand

Listing of Theranexus on Euronext Growth

Franck Mouthon and Mathieu Charvériat, founders of Theranexus, open the trading day in Paris

Theranexus is an innovative biopharmaceutical company specializing in the development of therapeutic products for the treatment of central nervous system diseases. Theranexus now has one product (THN102; a drug candidate combining a modulator of neuronal activity with a glial connexin modulator for the treatment of narcolepsy, a rare neurological disease) in Phase II clinical trial.

20/10/2017 IPO SMCP expand

SMCP lists on Euronext

16/10/2017 IPO Adeunis expand

Listing of Adeunis on Euronext Growth

Listing of Adeunis on Euronext Growth

Pascal Saguin , CEO of Adeunis,opens the trading day in Paris.

Adeunis specializes in the design, manufacturing and marketing of connected objects and Internet of Things (IoT) and machine-to-machine (M2M)-based radio frequency transmission solutions for use in sectors including smart building, remote energy data management, industrial optimization, connected agriculture, transport, infrastructure, sport, services, etc. Also, the group designs and develops customized radio solutions tailored to the specific needs of customers. The group's activity is organized around 3 families of products:

  • long-range radiofrequency transmission modules;
  • ready-to-use wireless transmission systems: radio modems, radio frame transmitters and receivers, wireless communication gateways, telemetry systems, data retrieval systems, radio temperature transmitters, remote controls, etc.;
  • wireless communication systems: audio conferencing systems and portable radio terminals for secure and confidential communications in noisy or harsh environments, sold under Vokkero brand.
13/10/2017 Icade's first Green Bond expand

Icade's first Green Bond

Olivier Wigniolle, CEO of Icade, and Victoire Aubry, CFO, celebrate the launch of their first Green Bond.

As an investor and a developer, Icade is an integrated real estate player which designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the cities— local authorities and communities, companies and employees, institutions and associations… As a commercial and healthcare property investor (portfolio value of €9.9bn as of 06/30/17) and as a property developer (2016 economic revenues of €1,005m), Icade is able to reinvent the real estate business and foster the emergence of tomorrow’s greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (SIIC). Its leading shareholder is the Caisse des dépôts Group.

For more information: www.icade.fr/en/

13/10/2017 IPO Biom'up expand

Listing of Biom'up on Euronext

Etienne Binant, Chief Executive, Biom'up, opens the trading day in Paris.

Biom'up specializes in research, development and manufacturing of implantable and resorbable collagen-based medical devices for surgery and regenerative medicine. The group especially offers haemostatic products that help control bleeding during surgery (Hemoblast) and collagen membranes that prevent organ adherence during surgery (Cova).

 

02/10/2017 Transfer of M2i to Euronext Growth expand

Transfer of M2i to Euronext Growth

George Seban, CEO M2i, closes the European trading day in Paris

M2i (Maison Internationale de l'Informatique) specializes in professional training services for the computer science, office automation, multimedia and management sectors. The group runs more than 2,000 internship programs in 35 centers in France.